Evidence map›Paper›PMID 29197946›Full record

ArticleNeurogenetics2018

First large genomic inversion in familial cerebral cavernous malformation identified by whole genome sequencing.

Stefanie Spiegler, Matthias Rath, Sabine Hoffjan, Philipp Dammann, Ulrich Sure, Axel Pagenstecher, Tim Strom, Ute Felbor

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Neurogenetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Biochemistry and biophysics reports · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Cerebrovascular disorders associated with genetic lesions.Cellular and molecular life sciences : CMLS · 2019
    Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Stefanie SpieglerDepartment of Human Genetics, University Medicine Greifswald, and Interfaculty Institute of Genetics and Functional Genomics, University of Greifswald, Fleischmannstraße 43, D-17475, Greifswald, Germany.ORCID 0000-0002-7405-2554
Matthias RathDepartment of Human Genetics, University Medicine Greifswald, and Interfaculty Institute of Genetics and Functional Genomics, University of Greifswald, Fleischmannstraße 43, D-17475, Greifswald, Germany.
Sabine HoffjanDepartment of Human Genetics, Ruhr-University, 44801, Bochum, Germany.
Philipp DammannDepartment of Neurosurgery, University Hospital Essen, University of Duisburg-Essen, 45147, Essen, Germany.
Ulrich SureDepartment of Neurosurgery, University Hospital Essen, University of Duisburg-Essen, 45147, Essen, Germany.
Axel PagenstecherDepartment of Neuropathology, University Hospital Giessen and Marburg, 35043, Marburg, Germany.
Tim StromInstitute of Human Genetics, Technische Universität München, 81675, Munich, Germany.
Ute FelborDepartment of Human Genetics, University Medicine Greifswald, and Interfaculty Institute of Genetics and Functional Genomics, University of Greifswald, Fleischmannstraße 43, D-17475, Greifswald, Germany. felbor@uni-greifswald.de.
Universitätsmedizin Greifswald · DEUniversity of Duisburg-Essen · DEHelmholtz Zentrum München · DERuhr University Bochum · DEUniversitätsklinikum Gießen und Marburg · DE

Funding

Deutsche Forschungsgemeinschaft FE432/9-1
6 · The paper itself

Abstract

Familial cerebral cavernous malformations (CCMs) predispose to seizures and hemorrhagic stroke. Molecular genetic analyses of CCM1, CCM2, and CCM3 result in a mutation detection rate of up to 98%. However, only whole genome sequencing (WGS) in combination with the Manta algorithm for analyses of structural variants revealed a heterozygous 24 kB inversion including exon 1 of CCM2 in a 12-year-old boy with familial CCMs. Its breakpoints were fine-mapped, and quantitative analysis on RNA confirmed reduced CCM2 expression. Our data expand the spectrum of CCM mutations and indicate that the existence of a fourth CCM disease gene is rather unlikely.

Indexed as

Chromosome InversionBrainCarrier ProteinsChildGenome-Wide Association StudyHemangioma, Cavernous, Central Nervous SystemHumansMalePedigreeWhole Genome SequencingCarrier ProteinsCCM2 protein, humanCCM2Cerebral cavernous malformationGenomic inversionWhole genome sequencing

Identifiers

PMID29197946
OpenAlexW2774529732

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.